News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,258 Results
Type
Article (5043)
Company Profile (11)
Press Release (70204)
Section
Business (22970)
Career Advice (124)
Deals (3077)
Drug Delivery (18)
Drug Development (11003)
Employer Resources (11)
FDA (1723)
Job Trends (2114)
News (38075)
Policy (2847)
Tag
Academia (594)
Alliances (6109)
Alzheimer's disease (261)
Approvals (1731)
Artificial intelligence (17)
Bankruptcy (18)
Best Places to Work (1948)
Breast cancer (25)
Cancer (199)
Cardiovascular disease (27)
Career advice (110)
Cell therapy (39)
Clinical research (8706)
Collaboration (89)
COVID-19 (311)
C-suite (24)
Cystic fibrosis (89)
Data (260)
Diabetes (19)
Diagnostics (721)
Earnings (6379)
Events (10355)
Executive appointments (70)
FDA (1823)
Funding (110)
Gene therapy (29)
GLP-1 (139)
Government (500)
Healthcare (2760)
Infectious disease (326)
Inflammatory bowel disease (40)
IPO (1520)
Job creations (231)
Job search strategy (98)
Layoffs (39)
Legal (449)
Lung cancer (27)
Lymphoma (16)
Manufacturing (29)
MASH (26)
Medical device (1196)
Medtech (1197)
Mergers & acquisitions (1592)
Metabolic disorders (72)
NASH (18)
Neuroscience (324)
NextGen Class of 2024 (973)
Non-profit (2420)
Northern California (241)
Obesity (33)
Opinion (28)
Parkinson's disease (36)
Patents (15)
People (8850)
Phase I (2575)
Phase II (4155)
Phase III (2877)
Pipeline (80)
Postmarket research (282)
Preclinical (1186)
Radiopharmaceuticals (21)
Rare diseases (117)
Real estate (489)
Regulatory (2119)
Research institute (569)
Resumes & cover letters (15)
Series A (15)
Southern California (193)
Startups (579)
United States (1987)
Vaccines (48)
Weight loss (20)
Date
Last 7 days (98)
Last 30 days (317)
Last 365 days (4886)
2024 (4872)
2023 (5668)
2022 (6766)
2021 (7817)
2020 (7535)
2019 (7003)
2018 (5199)
2017 (3994)
2016 (3933)
2015 (4100)
2014 (2888)
2013 (2130)
2012 (2115)
2011 (2182)
2010 (1642)
Location
Africa (95)
Asia (3906)
Australia (731)
California (527)
Canada (144)
China (30)
Colorado (19)
Connecticut (55)
Europe (9869)
Florida (51)
Georgia (30)
Illinois (52)
Indiana (24)
Japan (22)
Maryland (75)
Massachusetts (379)
Michigan (16)
Minnesota (21)
New Jersey (135)
New York (155)
North Carolina (129)
Northern California (241)
Ohio (24)
Pennsylvania (122)
South America (104)
Southern California (193)
Texas (75)
Washington State (39)
75,258 Results for "cystic fibrosis foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
November 18, 2024
·
4 min read
Earnings
Vertex Tops Q3 Forecast on Strength of Cystic Fibrosis Sales, Raises Full-Year Revenue Guidance
Coming off of a strong third quarter, Vertex Pharmaceuticals is nearing several important milestones, including the potential approvals of vanzacaftor triple in cystic fibrosis and the non-opioid therapy suzetrigine in pain—both slated for January 2025.
November 5, 2024
·
2 min read
·
Tristan Manalac
Genetown
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
Prime Medicine, Inc. (Nasdaq: PRME) today announced that the Cystic Fibrosis Foundation (CF Foundation) has agreed to provide the Company with up to $15 million to support the development of Prime Editors for the treatment of Cystic Fibrosis (CF).
January 25, 2024
·
6 min read
BioCapital
Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF
Today, the Cystic Fibrosis Foundation announced that it will provide up to $15 million to Prime Medicine for preclinical research into gene editing for cystic fibrosis.
January 25, 2024
·
3 min read
Drug Development
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
4D Molecular Therapeutics announced that interim data from the Phase 1/2 AEROW clinical trial evaluating aerosolized 4D-710 for treatment of cystic fibrosis lung disease will be presented at the 47th European Cystic Fibrosis Conference, taking place in Glasgow, UK.
May 30, 2024
·
6 min read
Genetown
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
Vertex Pharmaceuticals Incorporated announced that data on TRIKAFTA®, also known in the European Union and in the U.K. as KAFTRIO® in combination with ivacaftor, were presented at this year’s European Cystic Fibrosis Society’s 47th European Cystic Fibrosis Conference held June 5-8, 2024, in Glasgow, Scotland.
June 7, 2024
·
13 min read
Biotech Beach
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference
Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference.
June 7, 2024
·
7 min read
Drug Development
Vertex Finally Reaches Pricing Deal With England’s NHS for Cystic Fibrosis Drugs
Vertex Pharmaceuticals’ three cystic fibrosis drugs—Kaftrio/Trikafta, Symkevi and Orkambi—will now be available through England’s National Health Service, following the signing of a long-term reimbursement agreement.
June 21, 2024
·
2 min read
·
Tristan Manalac
Business
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Sail Biomedicines, Inc. today provided an update on its research funded by the Cystic Fibrosis Foundation (CF Foundation), with preclinical data that suggest that Sail’s Endless RNA™ (eRNA™) may offer the potential to treat the 10%-15% of people with CF for whom existing treatments are not an option.
January 5, 2024
·
4 min read
Press Releases
ReCode Therapeutics Presents Preclinical Data from its Cystic Fibrosis Program at the 2024 North American Cystic Fibrosis Conference (NACFC) in Boston
September 27, 2024
·
4 min read
1 of 7,526
Next
